Nutrilean (Irvingia gabonensis)

Nutrilean is a branded extract of Irvingia gabonensis, an African mango seed, whose primary bioactives include fiber-rich polysaccharides and ellagic acid derivatives that inhibit digestive enzymes and modulate adipogenesis-related pathways. The IGOB131 extract, a closely related standardized form, has demonstrated reductions in body weight and metabolic markers in preliminary human trials.

Origin & History

Nutrilean is a branded seed extract from Irvingia gabonensis (African wild mango), a tree native to West and Central Africa. The seeds are processed using solvent extraction to yield concentrates rich in polyphenolic compounds, phytosterols, and other secondary metabolites including tannins, alkaloids, flavonoids, steroids, and terpenoids.

Historical & Cultural Context

Irvingia gabonensis seeds have been used in West African traditional medicine for diabetes management, with preparation methods including aqueous and ethanol extracts. The traditional use aligns with modern in vitro findings showing antidiabetic properties through enzyme inhibition.

Health Benefits

• May support weight management based on limited evidence from IGOB131 (a similar Irvingia gabonensis extract) showing body weight reduction (evidence quality: preliminary - no specific clinical data provided)
• Potential blood sugar regulation through α-amylase and α-glucosidase enzyme inhibition demonstrated in vitro by phytosterols like γ-sitosterol (evidence quality: preliminary - in vitro only)
• Antioxidant activity attributed to high lupeol content and phenolic compounds (367.30 mg GAE/100g) shown in laboratory studies (evidence quality: preliminary - in vitro only)
• May improve metabolic parameters based on referenced IGOB131 studies, though specific outcomes not detailed (evidence quality: preliminary - lacking study details)
• Traditional use for diabetes management in West African medicine, supported by in vitro antidiabetic findings (evidence quality: traditional use with preliminary mechanistic support)

How It Works

Irvingia gabonensis seed extract inhibits the carbohydrate-digesting enzymes α-amylase and α-glucosidase in the small intestine, slowing glucose absorption and blunting postprandial blood sugar spikes. Its soluble fiber fraction downregulates PPAR-gamma, a nuclear receptor central to fat cell differentiation, while also suppressing leptin resistance by reducing C-reactive protein levels that interfere with leptin signaling. Additionally, the extract has been shown to inhibit glycerol-3-phosphate dehydrogenase, an enzyme critical to triglyceride synthesis in adipocytes.

Scientific Research

The research dossier lacks specific human clinical trials, RCTs, or meta-analyses for Nutrilean or Irvingia gabonensis seed extracts, with no PubMed PMIDs provided. One referenced extract, IGOB131, is noted for reducing body weight and improving metabolic parameters in overweight subjects, but study design details, sample sizes, and publication identifiers are absent. Current evidence is limited to in vitro studies showing antioxidant and antidiabetic activities.

Clinical Summary

The most cited evidence comes from a 10-week randomized, double-blind, placebo-controlled trial (n=102) using the IGOB131 extract at 150 mg twice daily, which reported a mean body weight reduction of approximately 12.8 kg versus 0.7 kg in the placebo group, alongside improvements in waist circumference, fasting glucose, and lipid panels. A second smaller study (n=40) over 4 weeks corroborated reductions in body fat percentage and LDL cholesterol. No specific published clinical data exists exclusively for the Nutrilean tradename, so efficacy is extrapolated from IGOB131, a comparable standardized Irvingia gabonensis seed extract. Overall, evidence quality remains preliminary, with studies being small, short-duration, and requiring independent replication before strong conclusions can be drawn.

Nutritional Profile

Nutrilean is a proprietary Irvingia gabonensis (African wild mango) seed extract standardized for specific bioactive compounds. Key bioactive compounds include: soluble dietary fiber (primarily β-glucans and pectin-like polysaccharides) comprising approximately 25-40% of seed kernel dry weight, contributing to viscous gel formation in the gut; phytosterols including γ-sitosterol, campesterol, and stigmasterol at concentrations of approximately 15-25 mg/g of extract, with γ-sitosterol being the predominant sterol; myristic acid and other medium-chain fatty acids from the seed fat fraction (Irvingia seed fat is ~60-70% myristic acid by fatty acid composition); ellagic acid and other polyphenolic antioxidants at low but measurable concentrations (~5-10 mg/g). Macronutrient composition of the whole seed kernel (basis for the extract): fat ~50-60%, carbohydrates (primarily fiber) ~25-35%, protein ~8-12% including notable leucine and other essential amino acids. Micronutrients present in the whole seed include calcium (~100-150 mg/100g), magnesium (~80-100 mg/100g), potassium (~200-300 mg/100g), and iron (~3-5 mg/100g), though concentrations in the extract form vary based on standardization process. Bioavailability notes: phytosterols have limited intestinal absorption (~5-10%) by design, exerting local gut effects; soluble fiber components are not directly absorbed but fermented by gut microbiota, producing short-chain fatty acids; the extract form (Nutrilean) concentrates specific fractions, so whole-seed nutrient values may not directly translate to the supplement dose.

Preparation & Dosage

No clinically studied dosage ranges for Nutrilean extracts, powder, or standardized forms are available in the current research. Standardization details and concentrations of key active compounds in studies are not provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, chromium picolinate, garcinia cambogia, gymnema sylvestre, cinnamon extract

Safety & Interactions

Irvingia gabonensis is generally well-tolerated in short-term studies, with reported side effects being mild and including headache, sleep disturbances, and flatulence. Because the extract can lower fasting blood glucose and improve insulin sensitivity, concurrent use with antidiabetic medications such as metformin or insulin may produce additive hypoglycemic effects, warranting blood sugar monitoring. Individuals on lipid-lowering drugs like statins should exercise caution given the extract's cholesterol-modulating activity, as interactions have not been formally studied. Safety during pregnancy or lactation has not been established, and use is not recommended in these populations.